About
Small molecule for neurological conditions
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
5
As Collaborator
1
Total Enrollment
245
By Phase
PHASE2: 1NA: 4PHASE1: 1
By Status
COMPLETED: 5TERMINATED: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Today
Hover over trial bars to see details
Recent Trials
NCT04148573Lead Sponsor
Clinical Trial to Evaluate Safety, Tolerability and Efficacy of NFX88 in SCI
PHASE2Completed
44 participants
Started: Oct 1, 2019 · Completed: Jul 20, 2022
NCT02166827Lead Sponsor
Effects of a NeuroAD System, for the Treatment of Alzheimer Disease
NATerminated
1 participants
Started: Nov 30, 2014 · Completed: Nov 30, 2015
NCT01825330Lead Sponsor
Effect of NeuroAD on the Cognitive Function of Alzheimer Patients
NACompleted
131 participants
Started: Oct 31, 2013 · Completed: Mar 31, 2016
NCT01825317Lead Sponsor
Effect of NeuroAD on Alzheimer Patients
NACompleted
32 participants
Started: Mar 31, 2013 · Completed: Dec 31, 2013
NCT01504958Collaborator
Effects of a Combined Transcranial Magnetic Stimulation (TMS) and Cognitive Training in Alzheimer Patients
NACompleted
22 participants
Started: Dec 31, 2010 · Completed: May 31, 2015
Locations (1)
Headquarters
Madrid, Spain
Map
Loading map...